保険医療管理学

128  件  
※ 登録方法の違いにより重複して表示されている場合があります。

  1. Ogino M, Kameda T, Mutsuda Y, Tanaka H, Takahashi J, Okazaki M, Ai M, Ohkawa R: Development of internal standard for lipoprotein subclass analysis using dual detection gel-permeation high-performance liquid chromatography system. Bioscience reports. 2022.05; 42 (6): ( PubMed , DOI )

  2. Hayashi T, Ai M, Goto S, Nakamura M, Nagaike H, Suzuki R, Abe Y, Ohta M, Ito Y, Hirano T: Circadian Rhythm of Subspecies of Low-Density Lipoprotein-Cholesterol and High-Density Lipoprotein-Cholesterol in Healthy Subjects and Patients with Type 2 Diabetes. Journal of atherosclerosis and thrombosis. 2022.03; ( PubMed , DOI )

  1. Yokoyama Minato, Ishioka Junichiro, Toba Mikayo, Fukushima Hiroshi, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Ai Masumi, Fushimi Kiyohide, Fujii Yasuhisa: Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018(和訳中) International Journal of Urology. 2021.12; 28 (12): 1268-1272. ( 医中誌 )

  2. Morimoto Nobuhisa, Urayama Kevin, Tanaka Akira, Ai Masumi: Relationship between dietary fibre to carbohydrate ratio and mortality risk in the NHANES INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2021.09; 50

  3. Yokoyama Shinji, Remaley Alan T., Sampson Maureen, Ai Masumi, Okazaki Mitsuyo: Validation by HPLC analyses of new equations for estimating cholesterol in plasma lipoprotein subfractions BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. 2021.09; 1866 (9): 158986. ( PubMed , DOI )

  4. Yokoyama Minato, Ishioka Junichiro, Toba Mikayo, Fukushima Hiroshi, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Ai Masumi, Fushimi Kiyohide, Fujii Yasuhisa: Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018 INTERNATIONAL JOURNAL OF UROLOGY. 2021.09; 28 (12): 1268-1272. ( PubMed , DOI )

  5. Nakamura Marie, Yamamoto Yasushi, Imaoka Wataru, Kuroshima Toshio, Toragai Ryoko, Ito Yasuki, Kanda Eiichiro, Schaefer Ernst J., Ai Masumi: Relationships between Smoking Status, Cardiovascular Risk Factors, and Lipoproteins in a Large Japanese Population Journal of Atherosclerosis and Thrombosis. 2021.09; 28 (9): 942-953. ( 医中誌 )

  6. Ikezaki H., Nakashima R., Ai M., Okazaki M., Kohzuma T., Schaefer E. J.: RELATIONSHIP BETWEEN DIETARY VITAMIN D INTAKE, OBESITY, AND TWENTY LIPOPROTEIN SUBCLASSES: RESULTS FROM THE KYUSHU AND OKINAWA POPULATION STUDY (KOPS) ATHEROSCLEROSIS. 2021.08; 331 E163-E164.

  7. Kayamori Y, Nakamura M, Kishi K, Miida T, Nishimura K, Okamura T, Hirayama S, Ohmura H, Yoshida H, Ai M, Tanaka A, Sumino H, Murakami M, Inoue I, Teramoto T, Yokoyama S: Comparison of the Japan Society of Clinical Chemistry reference method and CDC method for HDL and LDL cholesterol measurements using fresh sera. Practical laboratory medicine. 2021.05; 25 e00228. ( PubMed , DOI )

  8. Nakamura Marie, Yamamoto Yasushi, Imaoka Wataru, Kuroshima Toshio, Toragai Ryoko, Ito Yasuki, Kanda Eiichiro, Schaefer Ernst J., Ai Masumi: Relationships between Smoking Status, Cardiovascular Risk Factors, and Lipoproteins in a Large Japanese Population JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS. 2021; 28 (9): 942-953. ( PubMed , DOI )

  1. Ikezaki Hiroaki, Furusyo Norihiro, Yokota Yuya, Ai Masumi, Asztalos Bela F., Murata Masayuki, Hayashi Jun, Schaefer Ernst J.: Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression Journal of Atherosclerosis and Thrombosis. 2020.10; 27 (10): 1108-1122. ( 医中誌 )

  2. Kitazawa Toru, Seino Hiroaki, Ohashi Hiroshi, Inazawa Takeshi, Inoue Masahiro, Ai Masumi, Fujishiro Midori, Kuroda Hisamoto, Yamada Masayo, Anai Motonobu, Ishihara Hisamitsu: Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes: A randomized, 24-week, open-label, controlled trial (STOP-OB) DIABETES OBESITY & METABOLISM. 2020.09; 22 (9): 1659-1663. ( PubMed , DOI )

  1. Hsu Hung, Hsu Powen, Cheng Ming-Hui, Ito Yasuki, Kanda Eiichiro, Schaefer Ernst J., Ai Masumi: 台湾における糖尿病前症および糖尿病におけるリポ蛋白質亜分画とグルコース恒常性(Lipoprotein Subfractions and Glucose Homeostasis in Prediabetes and Diabetes in Taiwan) Journal of Atherosclerosis and Thrombosis. 2019.10; 26 (10): 890-914. ( 医中誌 )

  2. Kitazawa T., Seino H., Ohashi H., Inazawa T., Inoue M., Ai M., Fujishiro M., Kuroda H., Yamada M., Anai M., Ishihara H.: Tofogliflozin is a better candidate than glimepiride for the third line oral agent added to the metformin plus DPP-4 inhibitor dual therapy: results of a randomised control trial DIABETOLOGIA. 2019.09; 62 S359.

  3. Ikezaki Hiroaki, Fisher Virginia A., Lim Elise, Ai Masumi, Liu Ching-Ti, Cupples L. Adrienne, Nakajima Katsuyuki, Asztalos Bela F., Furusyo Norihiro, Schaefer Ernst J.: Direct Versus Calculated LDL Cholesterol and C-Reactive Protein in Cardiovascular Disease Risk Assessment in the Framingham Offspring Study CLINICAL CHEMISTRY. 2019.09; 65 (9): 1102-1114. ( PubMed , DOI )

  4. Ikezaki Hiroaki, Furusyo Norihiro, Yokota Yuya, Ai Masumi, Bela Asztalos, Murata Masayuki, Hayashi Jun, Ernst Schaefer: Small dense LDLコレステロールによる頸動脈内膜中膜肥厚の進行予測(Small Dense Low Density Lipoprotein Cholesterol Predict Carotid Intimal Medial Thickness Progression) 日本動脈硬化学会総会プログラム・抄録集. 2019.07; 51回 2-P. ( 医中誌 )

  5. Shingai Masumi, Niijima Ren, Kobayashi Yuto, Miyadera Ryosuke, Murayama Akihiko, Mukai Shinji: 3D motion captureを用いた主観的な椅子着座姿勢の特徴　20代の理学療法士によって感じ取られた椅子着座姿勢の認識(Characteristics of Subjective Chair Sitting Posture Using 3D Motion Capture: Recognition of a Chair Sitting Posture Felt By a 20's Physical Therapist) Journal of Physical Therapy Science. 2019.07; 31 (Suppl.1): 7. ( 医中誌 )

  6. Schaefer Ernst J., Ikezaki Hiroaki, Ai Masumi, Nakajima Katsuyuki, Cupples L. Adrienne: Framingham第2世代コホート研究における心血管疾患の予測(The Prediction of Cardiovascular Disease in the Framingham Offspring Study) 日本動脈硬化学会総会プログラム・抄録集. 2019.07; 51回 STML-1. ( 医中誌 )

  7. Hung Hsu, Powen Hsu, Ming-Hui Cheng, Yasuki Ito, Eiichiro Kanda, Ernst J Schaefer, Masumi Ai: Lipoprotein Subfractions and Glucose Homeostasis in Prediabetes and Diabetes in Taiwan. J. Atheroscler. Thromb.. 2019.02; 26 (10): 890-914. ( PubMed , DOI )

  1. Hisamitsu Ishihara, Motonobu Anai, Hiroaki Seino, Toru Kitazawa, Hiroshi Ohashi, Masumi Ai, Masahiro Inoue, Midori Fujishiro, Takeshi Inazawa, Hisamoto Kuroda, Masayo Yamada: Rationale and Design of the STOP-OB Study for Evaluating the Effects of Tofogliflozin and Glimepiride on Fat Deposition in Type 2 Diabetes Patients Treated with Metformin/DPP-4 Inhibitor Dual Therapy. Diabetes Ther. 2018.10; 9 (5): 2117-2125. ( PubMed , DOI )

  2. Ai Masumi, Yamamoto Yasushi, Toragai Ryoko, Kuroshima Toshio, Morimoto Nobuhisa, Kanda Eiichiro, Imaoka Wataru: REFERENCE RANGE OF SERUM CONCENTRATION OF SMALL DENSE LDL CHOLESTEROL FOR HEALTH CHECK-UP ATHEROSCLEROSIS SUPPLEMENTS. 2018.06; 32 55.

  3. Hiromasa Goto, Tomoya Mita, Yoshio Fujitani, Shimpei Fujimoto, Kiyohito Takahashi, Hiroaki Satoh, Takahisa Hirose, Toru Hiyoshi, Masumi Ai, Yosuke Okada, Hideki Nishimura, Hisamoto Kuroda, Toshiki Matsubara, Masahiko Gosho, Hitoshi Ishii, Hirotaka Watada: Effects of linagliptin versus voglibose on treatment-related quality of life in patients with type 2 diabetes: sub-analysis of the L-STEP study. Endocr. J.. 2018.04; 65 (6): 657-668. ( PubMed , DOI )

  4. Nobuhisa Morimoto, Chikako Kasuga, Airi Tanaka, Keiko Kamachi, Masumi Ai, Kevin Y Urayama, Akira Tanaka: Association between dietary fibre:carbohydrate intake ratio and insulin resistance in Japanese adults without type 2 diabetes. Br. J. Nutr.. 2018.03; 119 (6): 620-628. ( PubMed , DOI )

  1. Kawamura Hiroshi, Hsu Powen, Kanda Eiichiro, Kohzuma Takuji, Ai Masumi: 2型糖尿病(T2DM)に対する将来の血糖管理のための指標としてのグリコアルブミン(GA)/ヘモグロビンA1c(HbA1c)(GA/HbA1c indicator for future glycemic control for T2DM) 日本動脈硬化学会総会プログラム・抄録集. 2017.06; 49回 266. ( 医中誌 )

  2. Anne P Beigneux, Kazuya Miyashita, Michael Ploug, Dirk J Blom, Masumi Ai, MacRae F Linton, Weerapan Khovidhunkit, Robert Dufour, Abhimanyu Garg, Maureen A McMahon, Clive R Pullinger, Norma P Sandoval, Xuchen Hu, Christopher M Allan, Mikael Larsson, Tetsuo Machida, Masami Murakami, Karen Reue, Peter Tontonoz, Ira J Goldberg, Philippe Moulin, Sybil Charrière, Loren G Fong, Katsuyuki Nakajima, Stephen G Young: Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia. N. Engl. J. Med.. 2017.04; 376 (17): 1647-1658. ( PubMed , DOI )

  3. Hiroaki Ikezaki, Masumi Ai, Ernst J Schaefer, Seiko Otokozawa, Bela F Asztalos, Katsuyuki Nakajima, Yanhua Zhou, Ching-Ti Liu, Paul F Jacques, L Adrienne Cupples, Norihiro Furusyo: Cardiovascular disease prevalence and insulin resistance in the Kyushu-Okinawa Population Study and the Framingham Offspring Study. J Clin Lipidol. 2017.02; 11 (2): 348-356. ( PubMed , DOI )

  1. Yoshio Fujitani, Shimpei Fujimoto, Kiyohito Takahashi, Hiroaki Satoh, Takahisa Hirose, Toru Hiyoshi, Masumi Ai, Yosuke Okada, Masahiko Gosho, Tomoya Mita, Hirotaka Watada: Effects of linagliptin monotherapy compared with voglibose on postprandial blood glucose responses in Japanese patients with type 2 diabetes: Linagliptin Study of Effects on Postprandial blood glucose (L-STEP). Diabetes Res. Clin. Pract.. 2016.11; 121 146-156. ( PubMed , DOI )

  2. Hiroaki Ikezaki, Masumi Ai, Ernst J Schaefer, Seiko Otokozawa, Bela F Asztalos, Katsuyuki Nakajima, Yanhua Zhou, Ching-Ti Liu, Paul F Jacques, L Adrienne Cupples, Norihiro Furusyo: Ethnic Differences in Glucose Homeostasis Markers between the Kyushu-Okinawa Population Study and the Framingham Offspring Study. Sci Rep. 2016.11; 6 36725. ( PubMed , DOI )

  3. Eiichiro Kanda, Masumi Ai, Mitsuyo Okazaki, Masayuki Yoshida, Yoshitaka Maeda: Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho. PLoS ONE. 2016; 11 (11): e0166459. ( PubMed , DOI )

  1. Powen Hsu, Masumi Ai, Eiichiro Kanda, Neng-Chun Yu, Hsiao-Lien Chen, Huan-Wen Chen, Ming-Hui Cheng, Takuji Kohzuma, Ernst J Schaefer, Masayuki Yoshida: A comparison of glycated albumin and glycosylated hemoglobin for the screening of diabetes mellitus in Taiwan. Atherosclerosis. 2015.09; 242 (1): 327-333. ( PubMed , DOI )

  2. Hiroaki Ikezaki, Norihiro Furusyo, Takeshi Ihara, Takeo Hayashi, Kazuya Ura, Satoshi Hiramine, Fujiko Mitsumoto, Koji Takayama, Masayuki Murata, Takuji Kohzuma, Masumi Ai, Ernst J Schaefer, Jun Hayashi: Glycated albumin as a diagnostic tool for diabetes in a general Japanese population. Metab. Clin. Exp.. 2015.06; 64 (6): 698-705. ( PubMed , DOI )

  1. Takashi Miida, Kunihiro Nishimura, Tomonori Okamura, Satoshi Hirayama, Hirotoshi Ohmura, Hiroshi Yoshida, Yoh Miyashita, Masumi Ai, Akira Tanaka, Hiroyuki Sumino, Masami Murakami, Ikuo Inoue, Yuzo Kayamori, Masakazu Nakamura, Tsutomu Nobori, Yukihisa Miyazawa, Tamio Teramoto, Shinji Yokoyama: Validation of homogeneous assays for HDL-cholesterol using fresh samples from healthy and diseased subjects. Atherosclerosis. 2014.03; 233 (1): 253-259. ( PubMed , DOI )

  2. Eiichiro Kanda, Masumi Ai, Renjiro Kuriyama, Masayuki Yoshida, Tatsuo Shiigai: Dietary acid intake and kidney disease progression in the elderly. Am. J. Nephrol.. 2014; 39 (2): 145-152. ( PubMed , DOI )

  3. Katsuyuki Nakajima, Takeaki Nagamine, Masaki Q Fujita, Masumi Ai, Akira Tanaka, Ernst Schaefer: Apolipoprotein B-48: a unique marker of chylomicron metabolism. Adv Clin Chem. 2014; 64 117-177. ( PubMed )

  1. Norihiro Furusyo, Masumi Ai, Mitsuyo Okazaki, Hiroaki Ikezaki, Takeshi Ihara, Takeo Hayashi, Satoshi Hiramine, Kazuya Ura, Takuji Kohzuma, Ernst J Schaefer, Jun Hayashi: Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women. Atherosclerosis. 2013.12; 231 (2): 238-245. ( PubMed , DOI )

  2. Eiichiro Kanda, Masumi Ai, Mitsuyo Okazaki, Yoshitaka Maeda, Sei Sasaki, Masayuki Yoshida: The association of very-low-density lipoprotein with ankle-brachial index in peritoneal dialysis patients with controlled serum low-density lipoprotein cholesterol level. BMC Nephrol. 2013; 14 212. ( PubMed , DOI )

  3. Eiichiro Kanda, Masumi Ai, Asami Iwamoto, Mitsuyo Okazaki, Yoshitaka Maeda, Sei Sasaki, Masayuki Yoshida: Relationship between Icodextrin use and decreased level of small low-density lipoprotein cholesterol fractioned by high-performance gel permeation chromatography. BMC Nephrol. 2013; 14 234. ( PubMed , DOI )

  4. Kanda E, Ai M, Yoshida M, Kuriyama R, Shiigai T: High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients. BMC Nephrol. 2013; 14 4. ( PubMed , DOI )

  1. Miida T, Nishimura K, Okamura T, Hirayama S, Ohmura H, Yoshida H, Miyashita Y, Ai M, Tanaka A, Sumino H, Murakami M, Inoue I, Kayamori Y, Nakamura M, Nobori T, Miyazawa Y, Teramoto T, Yokoyama S: A multicenter study on the precision and accuracy of homogeneous assays for LDL-cholesterol: comparison with a beta-quantification method using fresh serum obtained from non-diseased and diseased subjects. Atherosclerosis. 2012.11; 225 (1): 208-215. ( PubMed , DOI )

  2. Ai M: [Atherosclerosis (hypertension)]. Nippon Rinsho. 2012.05; 70 (5): 840-845. ( PubMed )

  3. Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J: Plasma glycated albumin level and atherosclerosis: Results from the Kyushu and Okinawa Population Study (KOPS). International journal of cardiology. 2012.05; ( PubMed , DOI )

  4. van Himbergen TM, Beiser AS, Ai M, Seshadri S, Otokozawa S, Au R, Thongtang N, Wolf PA, Schaefer EJ: Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer Disease: Results From the Framingham Heart Study. Archives of neurology. 2012.01; ( PubMed , DOI )

  1. Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J: Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS). Diabetologia. 2011.09; ( PubMed , DOI )

  2. Ai M, Otokozawa S, Asztalos BF, White CC, Cupples LA, Nakajima K, Lamon-Fava S, Wilson PW, Matsuzawa Y, Schaefer EJ: Adiponectin: An independent risk factor for coronary heart disease in men in the Framingham offspring Study. Atherosclerosis. 2011.08; 217 (2): 543-548. ( PubMed , DOI )

  3. Nakajima K, Nakano T, Tokita Y, Nagamine T, Inazu A, Kobayashi J, Mabuchi H, Stanhope KL, Havel PJ, Okazaki M, Ai M, Tanaka A: Postprandial lipoprotein metabolism: VLDL vs chylomicrons. Clin Chim Acta. 2011.07; 412 (15-16): 1306-1318. ( PubMed , DOI )

  4. Schaefer EJ, Otokozawa S, Ai M: Limitations of direct methods and the reference method for measuring HDL and LDL cholesterol. Clin Chem. 2011.07; 57 (7): 1081-3; author reply 1083. ( PubMed , DOI )

  5. Thongtang N, Ai M, Otokozawa S, Himbergen TV, Asztalos BF, Nakajima K, Stein E, Jones PH, Schaefer EJ: Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation. Am J Cardiol. 2011.02; 107 (3): 387-392. ( PubMed , DOI )

  1. Ai M, Yoshida M: [Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study]. Nihon Rinsho. 2010.11; 68 Suppl 9 285-290. ( PubMed )

  2. Otokozawa S, Ai M, Asztalos BF, White CC, Demissie-Banjaw S, Cupples LA, Nakajima K, Wilson PW, Schaefer EJ: Direct assessment of plasma low density lipoprotein and high density lipoprotein cholesterol levels and coronary heart disease: results from the Framingham Offspring Study. Atherosclerosis. 2010.11; 213 (1): 251-255. ( PubMed , DOI )

  3. Nakajima K, Kobayashi J, Mabuchi H, Nakano T, Tokita Y, Nagamine T, Imamura S, Ai M, Otokozawa S, Schaefer EF: Association of angiopoietin-like protein 3 with hepatic triglyceride lipase and lipoprotein lipase activities in human plasma. Ann Clin Biochem. 2010.09; 47 (Pt 5): 423-431. ( PubMed , DOI )

  4. Asztalos BF, Swarbrick MM, Schaefer EJ, Dallal GE, Horvath KV, Ai M, Stanhope KL, Austrheim-Smith I, Wolfe BM, Ali M, Havel PJ: Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women. J Lipid Res. 2010.08; 51 (8): 2405-2412. ( PubMed , DOI )

  5. Vega-López S, Matthan NR, Ausman LM, Harding SV, Rideout TC, Ai M, Otokozawa S, Freed A, Kuvin JT, Jones PJ, Schaefer EJ, Lichtenstein AH: Altering dietary lysine:arginine ratio has little effect on cardiovascular risk factors and vascular reactivity in moderately hypercholesterolemic adults. Atherosclerosis. 2010.06; 210 (2): 555-562. ( PubMed , DOI )

  6. Ai M, Otokozawa S, Asztalos BF, Ito Y, Nakajima K, White CC, Cupples LA, Wilson PW, Schaefer EJ: Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study. Clin Chem. 2010.06; 56 (6): 967-976. ( PubMed , DOI )

  1. Vega-López S, Matthan NR, Ausman LM, Ai M, Otokozawa S, Schaefer EJ, Lichtenstein AH: Substitution of vegetable oil for a partially-hydrogenated fat favorably alters cardiovascular disease risk factors in moderately hypercholesterolemic postmenopausal women Atherosclerosis. 2009; 207 (1): 208-212. ( PubMed , DOI )

  2. van Himbergen TM, Otokozawa S, Matthan NR, Schaefer EJ, Buchsbaum A, Ai M, van Tits LJ, de Graaf J, Stalenhoef AF: Familial Combined Hyperlipidemia Is Associated With Alterations in the Cholesterol Synthesis Pathway Arterioscler Thromb Vasc Biol. 2009; ( PubMed , DOI )

  3. Otokozawa S, Ai M, Van Himbergen T, Asztalos BF, Tanaka A, Stein EA, Jones PH, Schaefer EJ: Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels Atherosclerosis. 2009; 205 (1): 197-201. ( PubMed , DOI )

  4. Otokozawa S, Ai M, Diffenderfer MR, Asztalos BF, Tanaka A, Lamon-Fava S, Schaefer EJ: Fasting and postprandial apolipoprotein B-48 levels in healthy, obese, and hyperlipidemic subjects Metabolism. 2009; 58 (11): 1536-1542. ( PubMed , DOI )

  5. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ: Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans J Clin Invest. 2009; 119 (5): 1322-1334. ( PubMed , DOI )

  6. Ai M, Tanaka A, Shimokado K, Ohtani R, Inazu A, Kobayashi J, Mabuchi H, Nakano T, Nakajima K: A deficiency of cholesteryl ester transfer protein whose serum remnant-like particle-triglyceride significantly increased, but serum remnant-like particle-cholesterol did not after an oral fat load Ann Clin Biochem. 2009; 46 (Pt 6): 457-463. ( PubMed , DOI )

  7. van Himbergen TM, Matthan NR, Resteghini NA, Otokozawa S, Ai M, Stein EA, Jones PH, Schaefer EJ: Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers J Lipid Res. 2009; 50 (4): 730-739. ( PubMed , DOI )

  8. Asztalos BF, Swarbrick MM, Schaefer EJ, Dallal GE, Horvath KV, Ai M, Stanhope KL, Austrheim-Smith I, Wolfe BM, Ali M, Havel PJ: Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women J Lipid Res. 2009; ( PubMed , DOI )

  9. Ai M, Otokozawa S, Schaefer EJ, Asztalos BF, Nakajima K, Shrader P, Kathiresan S, Meigs JB, Williams G, Nathan DM: Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus Clin Chim Acta. 2009; 406 (1-2): 71-74. ( PubMed , DOI )

  1. Chiba T, Shinozaki S, Nakazawa T, Kawakami A, Ai M, Kaneko E, Kitagawa M, Kondo K, Chait A, Shimokado K: Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice Atherosclerosis. 2008; 196 (1): 68-75. ( PubMed , DOI )

  2. Ogita K, Ai M, Tanaka A, Ito Y, Hirano T, Yoshino G, Shimokado K: Serum concentration of small dense low-density lipoprotein-cholesterol during oral glucose tolerance test and oral fat tolerance test Clin Chim Acta. 2008; 387 (1-2): 36-41. ( PubMed , DOI )

  3. Ai M, Otokozawa S, Asztalos BF, Nakajima K, Stein E, Jones PH, Schaefer EJ: Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels Am J Cardiol. 2008; 101 (3): 315-318. ( PubMed , DOI )

  4. Lamon-Fava S, Diffenderfer MR, Barrett PH, Buchsbaum A, Nyaku M, Horvath KV, Asztalos BF, Otokozawa S, Ai M, Matthan NR, Lichtenstein AH, Dolnikowski GG, Schaefer EJ: Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins Arterioscler Thromb Vasc Biol. 2008; 28 (9): 1672-1678. ( PubMed , DOI )

  1. Ai M, Tanaka A, Shoji K, Ogita K, Hase T, Tokimitsu I, Shimokado K: Suppressive effects of diacylglycerol oil on postprandial hyperlipidemia in insulin resistance and glucose intolerance Atherosclerosis. 2007; 195 (2): 398-403. ( PubMed , DOI )

  2. Asano T, Kaneko E, Shinozaki S, Imai Y, Shibayama M, Chiba T, Ai M, Kawakami A, Asaoka H, Nakayama T, Mano Y, Shimokado K: Hyperbaric oxygen induces basic fibroblast growth factor and hepatocyte growth factor expression, and enhances blood perfusion and muscle regeneration in mouse ischemic hind limbs Circ J. 2007; 71 (3): 405-411. ( PubMed )

  3. Abe Y, Ai M, Kaneko M, Sawara M, Nagano K, Shimokado K: [Studies on factors related to delayed discharge of elderly patients from university hospitals] Nippon Ronen Igakkai Zasshi. 2007; 44 (5): 641-647. ( PubMed )

  4. Imai Y, Kaneko E, Asano T, Kumagai M, Ai M, Kawakami A, Kataoka K, Shimokado K: A novel contrast medium detects increased permeability of rat injured carotid arteries in magnetic resonance T2 mapping imaging J Atheroscler Thromb. 2007; 14 (2): 65-71. ( PubMed )

  5. Ogita K, Ai M, Tanaka A, Ito Y, Hirano T, Yoshino G, Shimokado K: Circadian rhythm of serum concentration of small dense low-density lipoprotein cholesterol Clin Chim Acta. 2007; 376 (1-2): 96-100. ( PubMed , DOI )

  6. Shinozaki S, Chiba T, Kokame K, Miyata T, Ai M, Kawakami A, Kaneko E, Yoshida M, Shimokado K: Site-specific effect of estradiol on gene expression in the adipose tissue of ob/ob mice Horm Metab Res. 2007; 39 (3): 192-196. ( PubMed , DOI )

  1. Ai M, Tanaka A, Ogita K, Shimokado K: Favorable effects of early insulin secretion by nateglinide on postprandial hyperlipidemia in patients with type 2 diabetes Diabetes Care. 2006; 29 (5): 1180. ( PubMed , DOI )

  1. Ai M, Tanaka A: [Guidelines for plasma lipid and lipoprotein concentration] Nippon Rinsho. 2001; 59 Suppl 2 759-762. ( PubMed )

  2. Ai M, Tanaka A, Tomie N, Ogita K, Sekine M, Numano F, Numano F: Triglyceride-rich lipoprotein cholesterol exceeds low-density lipoprotein cholesterol in hypertriglyceridemia patients Horm Metab Res. 2001; 33 (10): 612-617. ( PubMed , DOI )

  3. Ai M, Tanaka A, Ogita K, Sekinc M, Numano F, Numano F, Reaven GM: Relationship between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 diabetes J Am Coll Cardiol. 2001; 38 (6): 1628-1632. ( PubMed )

  4. Tanaka A, Ai M: [Hyper-remnant-like particles (RLP) lipoproteinemia] Nippon Rinsho. 2001; 59 Suppl 3 107-111. ( PubMed )

  5. Tanaka A, Ai M: [Receptor for apolipoprotein B48] Nippon Rinsho. 2001; 59 Suppl 2 339-343. ( PubMed )

  6. Ai M, Tanaka A, Baba T, Yui K, Numano F: Increased cholesteryl ester transfer protein and changes in lipid metabolism from initiating insulin therapy Ann N Y Acad Sci. 2001; 947 356-361. ( PubMed )

  7. Tanaka A, Ai M: [Hyperlipidemia, definition, cause, frequency] Nippon Rinsho. 2001; 59 Suppl 2 653-660. ( PubMed )

  8. Tanaka A, AI M, Kobayashi Y, Tamura M, Shimokado K, Numano F: Metabolism of triglyceride-rich lipoproteins and their role in atherosclerosis Ann N Y Acad Sci. 2001; 947 207-12; discussion 212-3. ( PubMed )

  1. Ai M, Tanaka A, Ogita K, Sekine M, Numano F, Numano F, Reaven GM: Relationship between hyperinsulinemia and remnant lipoprotein concentrations in patients with impaired glucose tolerance J Clin Endocrinol Metab. 2000; 85 (10): 3557-3560. ( PubMed )

  1. Nakamura Marie, Yamamoto Yasushi, Imaoka Wataru, Kuroshima Toshio, Toragai Ryoko, Ito Yasuki, Yoshida Hiroshi, Ai Masumi: Reference interval for serum concentration of small dense low-density lipoprotein cholesterol in the healthy Japanese population ANNALS OF CLINICAL BIOCHEMISTRY. 2022.07; 59 (4): 242-252. ( PubMed , DOI )

  2. 中村 麻里衣, 今岡 渉, 黒島 俊夫, 山本 泰司, 寅貝 良子, 藍 真澄: Small Dense LDL-Cholesterol値の健診・人間ドックにおける判定基準案(2021年時点) 新薬と臨牀. 2022.01; 71 (1): 3-12. ( 医中誌 )

  1. Ikezaki H., Yokota Y., Ai M., Asztalos B. F., Murata M., Hayashi J., Schaefer E. J.: ATHEROGENIC LIPOPROTEINS AND CAROTID INTIMAL MEDIAL THICKNESS PROGRESSION OVER 5 YEARS ATHEROSCLEROSIS. 2020.12; 315 E51.

  2. 藍 真澄: 【脂質異常症と動脈硬化update】食後高脂血症 糖尿病・内分泌代謝科. 2020.08; 51 (2): 92-97. ( 医中誌 )

  3. 後藤 聡, 林 俊行, 藍 真澄, 長池 弘江, 江波戸 彩乃, 大坂 直也, 藤川 大輝, 八島 広典, 高畑 洋, 深瀬 絢子, 佐藤 展子, 九島 秀樹, 広村 宗範, 小原 信, 森 雄作, 福井 智康, 平野 勉, 山岸 昌一: 2型糖尿病患者におけるsdLDL-CおよびLDL-TGの日内変動についての検討 糖尿病. 2020.08; 63 (Suppl.1): S-335. ( 医中誌 )

  4. 後藤 聡, 林 俊行, 平野 勉, 藍 真澄, 長池 弘江, 九島 秀樹, 広村 宗範, 小原 信, 森 雄作, 福井 智康, 山岸 昌一: 2型糖尿病患者におけるsd LDL-CおよびLDL-TGの日内変動についての検討 日本動脈硬化学会総会プログラム・抄録集. 2020.07; 52回 217. ( 医中誌 )

  5. 森本 靖久, 田中 啓之, 今岡 渉, 山本 泰司, 神田 英一郎, 藍 真澄: HDL-C、中性脂肪、血清アルブミン値が腎機能低下速度に及ぼす影響 日本腎臓学会誌. 2020.07; 62 (4): 385. ( 医中誌 )

  6. 石岡 淳一郎, 松崎 みどり, 吉岡 久子, 藍 真澄: 医学生・勤務医に対する社会保険医療制度教育の現状の質問票調査 新薬と臨牀. 2020.03; 69 (3): 352-361. ( 医中誌 )

  7. Ikezaki Hiroaki, Yokota Yuya, Ai Masumi, Asztalos Bela F., Murata Masayuki, Hayashi Jun, Schaefer Ernst J.: Small Dense Low-density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression CIRCULATION. 2020.03; 141 ( DOI )

  8. 池崎 裕昭, 横田 裕哉, 藍 真澄, Asztalos Bela, 村田 昌之, 林 純, Schaefer Ernst: 頸動脈内膜中膜複合体の肥厚進展予測因子としてのsmall dense LDLコレステロールの有用性 日本内科学会雑誌. 2020.02; 109 (Suppl.): 239. ( 医中誌 )

  9. Ikezaki Hiroaki, Furusyo Norihiro, Yokota Yuya, Ai Masumi, Asztalos Bela F., Murata Masayuki, Hayashi Jun, Schaefer Ernst J.: Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS. 2020; 27 (10): 1108-1122. ( PubMed , DOI )

  1. 阿部 庸子, 大内 修司, 鈴木 里彩, 中村 麻里衣, 藍 真澄, 金子 英司: 自殺企図なくインスリン多量自己注射をした78歳男性 日本老年医学会雑誌. 2019.10; 56 (4): 574. ( 医中誌 )

  2. 春日 千加子, 蒲池 桂子, 桝本 悠輔, 時田 佳治, 藍 真澄, 田中 明: 食事・運動介入プログラムによる食品摂取の変化が生活習慣病関連因子に及ぼす影響 糖尿病. 2019.07; 62 (7): 373-382. ( 医中誌 )

  3. 中村 麻里衣, 今岡 渉, 山本 泰司, 森本 靖久, 神田 英一郎, 藍 真澄: Small Dense LDL Cholesterolと喫煙の関連の検討　健診データを用いた横断研究 日本動脈硬化学会総会プログラム・抄録集. 2019.07; 51回 1-P. ( 医中誌 )

  4. 寅貝 良子, 今岡 渉, 山本 泰司, 黒島 俊夫, 中村 麻里衣, 神田 英一郎, 藍 真澄: 健診データを用いた超悪玉コレステロール(sdLDL-C)と喫煙の関連の検討 人間ドック. 2019.07; 34 (2): 300. ( 医中誌 )

  5. 池崎 裕昭, 横田 裕哉, Schaefer Ernst, 藍 真澄, 村田 昌之, 古庄 憲浩, 林 純: 直接法LDLコレステロール値と高感度CRP値の冠動脈疾患予測因子としての有用性 日本病院総合診療医学会雑誌. 2019.05; 15 (3): 239. ( 医中誌 )

  6. 藍 真澄: 【診療力を上げる!　症例問題集】(第10章)代謝・内分泌　症例問題　健診で著明な高LDLコレステロール血症を指摘された1例 内科. 2019.04; 123 (4): 1003-1005. ( 医中誌 )

  7. 池崎 裕昭, 横田 裕哉, 藍 真澄, 村田 昌之, 古庄 憲浩, 林 純: 冠動脈疾患予測因子としてのリポ蛋白の有用性 日本内科学会雑誌. 2019.02; 108 (Suppl.): 179. ( 医中誌 )

  1. 大内 修司, 沼沢 祥行, 鈴木 里彩, 佐々木 真理, 阿部 庸子, 藍 真澄, 金子 英司, 竹村 洋典: インスリンデグルデクの週4回投与で良好な血糖管理を得た血液透析患者の1例 日本内科学会関東地方会. 2018.12; 647回 46. ( 医中誌 )

  2. 今岡 渉, 山本 泰司, 寅貝 良子, 黒島 俊夫, 森本 靖久, 神田 英一郎, 藍 真澄: 健診・人間ドックでのSmall Dense LDL Cholesterol値の活用と基準値の検討 新薬と臨牀. 2018.06; 67 (6): 706-717. ( 医中誌 )

  3. 神田 英一郎, 藍 真澄, 岡崎 三代, 吉田 雅幸, 前田 益孝: HDLコレステロールサブクラスと、慢性腎臓病進行、動脈硬化およびKlothoとの関係についての研究 日本透析医会雑誌. 2018.04; 33 (1): 140-150. ( 医中誌 )

  4. 藍 真澄: 脂質異常症治療の課題　コレステロール 糖尿病. 2018.04; 61 (Suppl.1): S-114. ( 医中誌 )

  5. 藍 真澄: 脂質治療の展望-量から質へのパラダイムシフト　食後高脂血症にみるリポタンパクの質的変化 糖尿病. 2018.04; 61 (Suppl.1): S-45. ( 医中誌 )

  1. 寅貝 良子, 山本 泰司, 望月 茂, 黒島 俊夫, 今岡 渉, 藍 真澄: 健診・人間ドックでのsd LDL-C値の活用について 人間ドック. 2017.08; 32 (2): 318. ( 医中誌 )

  2. 寅貝 良子, 山本 泰司, 望月 茂, 黒島 俊夫, 今岡 渉, 藍 真澄: 健診・人間ドックでsd LDL-C値の活用について 人間ドック. 2017.08; 32 (2): 295. ( 医中誌 )

  3. 古庄 憲浩, 池崎 裕昭, 志水 元洋, 上山 貴嗣, 山嵜 奨, 加藤 禎史, 田中 佑樹, 浦 和也, 高山 耕治, 平峯 智, 加勢田 富士子, 林 武生, 小川 栄一, 豊田 一弘, 村田 昌之, 林 純, 藍 真澄: 耐糖能異常におけるインスリン分泌能・インスリン抵抗性の日米比較研究 日本病院総合診療医学会雑誌. 2017.07; 13 (1): 155. ( 医中誌 )

  4. 藍　真澄: 動脈硬化リスク・治療標的としてのTG,HDL 日本内科学会雑誌. 2017.04; 106 (4): 725-734.

  5. 藍 真澄: 【脂質異常症:実地診療におけるピットフォールから未来の治療まで】動脈硬化リスク・治療標的としてのTG、HDL　動脈硬化リスク・治療標的としてのTG、HDL 日本内科学会雑誌. 2017.04; 106 (4): 725-734. ( 医中誌 )

  6. 神田 英一郎, 藍 真澄, 岡崎 三代, 吉田 雅幸, 前田 益孝: HDLサブクラスは末梢動脈硬化およびKlothoにCKDステージ特異的に関係する 日本腎臓学会誌. 2017.04; 59 (3): 266. ( 医中誌 )

  7. 池崎 裕昭, 藍 真澄, 男澤 聖子, 中嶋 克行, 村田 昌之, 古庄 憲浩, 林 純: 耐糖能異常におけるインスリン分泌能・インスリン抵抗性の人種差の検討 糖尿病. 2017.04; 60 (Suppl.1): S-279. ( 医中誌 )

  1. 藍　真澄、吉田雅幸: レムナントリポ蛋白と血管病態 血管医学. 2009;

  2. 藍　真澄、吉田雅幸: 動脈硬化とバイオマーカー 分子心血管病. 2009;

  1. 藍真澄: 【動脈硬化のすべて】　動脈硬化危険因子の治療の実際とEBM　糖尿病と境界型 循環器科. 2006; 59 548-564.

  2. 藍真澄: 指導医のための保険診療概論　レセプトチェックの実際 Attending Eye. 2006; 2 (1): 70-75.

  1. 藍真澄: 指導医のための保険診療概論(その3) Attending Eye. 2005; 1 (3): 62-67.

  2. 藍真澄: 指導医のための保険診療概論　保険診療のルール Attending Eye. 2005; 1 (2): 80-85.

  3. 藍真澄, 下門顕太郎: 【生活習慣病のすべて】　生活習慣病を理解するための基礎知識　メタボリックシンドロームとは 臨床看護. 2005; 31 (13): 1866-1870.

  4. 藍真澄: 指導医のための保険診療概論(その1) Attending Eye. 2005; 1 (1): 78-83.

  1. 梅田尚季, 藍真澄, 中山徹, 川上明夫, 浅野哲一, 金子英司, 由井克昌, 吉田雅幸, 下門顕太郎: 長期間腰痛に悩まされた中年男性の1症例 日本未病システム学会雑誌. 2004; 10 (1): 168-170.

  2. 内田裕子, 寺内公一, 平光史朗, 久保田俊郎, 麻生武志, 阿部庸子, 荻田恭子, 藍真澄, 由井克昌, 下門顕太郎: 重症高脂血症合併妊娠の一例 日本産科婦人科学会東京地方部会会誌. 2004; 53 (4): 572-577.

  3. 藍真澄, 島田直樹, 近藤健文, 下門顕太郎: 「医師・歯科医師・薬剤師調査」の現状に関する検討　全保健所,全県,保健所設置市アンケート調査 厚生の指標. 2004; 51 (15): 28-33.

  1. 安達直人, 藍真澄, 鈴木仁一: 米国の診断群別所定報酬額支払い方式(DRG/PPS)における審査・監査機構 厚生の指標. 2003; 50 (7): 8-16.

  1. 藍　真澄、田中　明: 糖尿病における肥満、脂質代謝と動脈硬化症 別冊プラクティス−糖尿病と動脈硬化症. 2002;

  2. 藍　真澄、下門顕太郎: 生活習慣病の相互関連 臨床看護. 2002; 28 995-1002.

  3. 田中　明、藍　真澄: インスリン抵抗性とレムナントリポ蛋白 Therapeutic Research. 2002; 23 1544-1550.

  1. 古要俊也、北村　均、藍　真澄　他: C型慢性肝炎に対するインターフェロン治療効果とC型肝炎ウイルス超可変領域-1の治療前後での変化についての検討。 埼玉県医学会雑誌. 1998; 32 983-985.

このページの先頭へ▲